secwatch / observer
8-K filed October 9, 2026, 8:11 AM ET ticker LRN CIK 0001157408
leadership confidence high sentiment neutral materiality 0.60

Stride adds Fivespan's Dylan Haggart and Steven Guttentag to board, forms Capital Allocation Committee

Stride, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Steven Guttentag

Board Observer
LRN · Stride, Inc.
Effective
2026-10-08
Filed
October 9, 2026, 8:11 AM ET
Also on October 8, 2026, the Board appointed Dr. Guttentag to serve as the Board Observer, effective immediately.
Appointed

Steven Guttentag

Director
LRN · Stride, Inc.
Filed
October 9, 2026, 8:11 AM ET
Effective as of immediately following the conclusion of the 2026 Annual Meeting, the Board will increase its size from eight directors to ten directors, nine of whom will be independent, and Dr. Guttentag and Ms. Lawrence will be appointed to serve as directors on the Board, each with a term expiring at the 2027 Annual Meeting and until his or her successor is elected and qualified or until his or her earlier resignation, death or removal.
Appointed

Allison Lawrence

Director
LRN · Stride, Inc.
Filed
October 9, 2026, 8:11 AM ET
Effective as of immediately following the conclusion of the 2026 Annual Meeting, the Board will increase its size from eight directors to ten directors, nine of whom will be independent, and Dr. Guttentag and Ms. Lawrence will be appointed to serve as directors on the Board, each with a term expiring at the 2027 Annual Meeting and until his or her successor is elected and qualified or until his or her earlier resignation, death or removal.
Departed

Allison Lawrence

Director
LRN · Stride, Inc.
Successor
Dylan Haggart
Filed
October 9, 2026, 8:11 AM ET
In connection with the foregoing, on October 8, 2026, Ms. Lawrence tendered her resignation from the Board and from the Compensation Committee of the Board, effective immediately prior to the Appointment Date and Time. Following the effective time of her resignation, Ms. Lawrence will serve as a non-voting observer to the Board until she is re-appointed to the Board immediately following the conclusion of the 2026 Annual Meeting. Ms. Lawrence’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Appointed

Dylan Haggart

Director
LRN · Stride, Inc.
Filed
October 9, 2026, 8:11 AM ET
On October 8, 2026, the Board (i) appointed Mr. Haggart, with effect as from the Appointment Date and Time, to serve as a director on the Board with an initial term expiring at the 2026 Annual Meeting, to fill a vacancy created by Ms. Allison Lawrence’s resignation (discussed below)

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Steven Guttentag was appointed as Board Observer at Stride, Inc..

Action
appointed
Role
Board Observer
Exact text from the filing
Also on October 8, 2026, the Board appointed Dr. Guttentag to serve as the Board Observer, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Steven Guttentag was appointed as Director at Stride, Inc..

Action
appointed
Role
Director
Exact text from the filing
Effective as of immediately following the conclusion of the 2026 Annual Meeting, the Board will increase its size from eight directors to ten directors, nine of whom will be independent, and Dr. Guttentag and Ms. Lawrence will be appointed to serve as directors on the Board, each with a term expiring at the 2027 Annual Meeting and until his or her successor is elected and qualified or until his or her earlier resignation, death or removal.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.85

Allison Lawrence was appointed as Director at Stride, Inc..

Action
appointed
Role
Director
Exact text from the filing
Effective as of immediately following the conclusion of the 2026 Annual Meeting, the Board will increase its size from eight directors to ten directors, nine of whom will be independent, and Dr. Guttentag and Ms. Lawrence will be appointed to serve as directors on the Board, each with a term expiring at the 2027 Annual Meeting and until his or her successor is elected and qualified or until his or her earlier resignation, death or removal.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Allison Lawrence resigned as Director at Stride, Inc..

Action
resigned
Role
Director
Exact text from the filing
In connection with the foregoing, on October 8, 2026, Ms. Lawrence tendered her resignation from the Board and from the Compensation Committee of the Board, effective immediately prior to the Appointment Date and Time. Following the effective time of her resignation, Ms. Lawrence will serve as a non-voting observer to the Board until she is re-appointed to the Board immediately following the conclusion of the 2026 Annual Meeting. Ms. Lawrence’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dylan Haggart was appointed as Director at Stride, Inc..

Action
appointed
Role
Director
Exact text from the filing
On October 8, 2026, the Board (i) appointed Mr. Haggart, with effect as from the Appointment Date and Time, to serve as a director on the Board with an initial term expiring at the 2026 Annual Meeting, to fill a vacancy created by Ms. Allison Lawrence’s resignation (discussed below)
View on SEC.gov

Stride, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-26-114863
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.